II. Epidemiology: Lifetime Prevalence
- U.S. General Population: 6%
- Women: 8%
- Men: 4%
- U.S. Veterans: 7%
- Women: 13%
- Men: 6%
- Age 18-29: 15%
- Age 30-65: 9-10%
- Age >65 years: 4%
- References
- Schnurr, Epidemiology and Impact of PTSD (US VA), accessed 3/138/2023
- Goldstein (2016) Soc Psychiatry Psychiatr Epidemiol 51(8):1137-48 +PMID: 27106853 [PubMed]
III. Pathophysiology
IV. Causes: Trauma triggers for PTSD
V. Risk Factors
VI. Symptoms
- Intrusive re-experiencing the Trauma
- Increased autonomic arousal
- Insomnia
- Angry outbursts or other anti-social behaviors
- Hyper-vigilance and suspiciousness
- Exaggerated startle response
- Change in activity, appetite, sleep, sex and social functioning
- Unable to rest (pacing)
- Cognitive symptoms
- Poor concentration, memory decision making, problem solving or attention
- Intrusive images or Nightmares
- Emotional symptoms
- Agitation or irritability
- Anxiety, apprehension or fear
- Depressed mood or guilt
- Denial or blaming
- Emotional numbing or dissociation
- Physical symptoms
- Chills or sweats
- Dizziness, Faintness or weakness
- Muscle Tremors or twitching
- Dyspnea
- Bruxism
- Increased Blood Pressure
- Tachycardia (or Palpitations)
- Gastrointestinal upset
VII. History
- Reexperiencing
- Times that you relive event when it is not happening?
- Think about event when you do not want to (e.g. Nightmares)?
- Fear and anxiousness when reminded of event?
- Avoidance
- Avoid specific places, people, conversation topics or situations since the event?
- Avoid previously pleasurable activities?
- Less connected with family and friends?
- Others notice you are unhappy or detached?
- Change in life goals?
- Increased Arousal
VIII. Associated Conditions
- Major Depression
- Substance Abuse
- Aggressive outbursts
- Panic Attacks or Panic Disorder
- Profound demoralization and low self esteem
- Pervasive guilt, grief or suspiciousness
- Suicidal Ideation
- Somatic complaints
- Interpersonal and work related Impairment
- Sexual Dysfunction
IX. Diagnosis: Screening
- Precautions
- PTSD Screening should include Suicidality screening
- Indications
- History of likely Posttraumatic Stress Disorder Triggers
- Undifferentiated Mood Disorder
- Military Veterans
- Screen yearly for 5 years after military seperation, then once every 5 years thereafter
- See Healthcare of the Military Veteran
- Screening Tools
- Diagnostic Tools
- Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
- Thirty item diagnostic tool requiring up to one hour for clinician to administer
- PTSD Checklist for DSM-5 (PCL-5)
- https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp
- Self-reported 20 item questionnaire, validated for civilian and military patients
- DSM-5 Criteria for Posttraumatic Stress Disorder (DSM-5)
- Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
X. Diagnosis: DSM-V Criteria (over age 6 years old)
- See Spectrum of Trauma Response
- More than 1 MONTH of the following criteria
- Results in significantly impaired function
- Not due to other conditions
- Actual or threatened EXPOSURE to risk of death, serious injury or Sexual Violence (1 or more required)
- RE-EXPERIENCING the Trauma (1 or more required)
- Distressing, intrusive, recurrent event memories (or play themes in children over age 6 years)
- Recurrent related Nightmares
- Flashbacks in which the event is re-lived (dissociative reactions)
- Intense emotional distress or physiologic reaction in response to associated triggers
- AVOIDANCE (1 or more required)
- Avoid related distressing memories, thoughts or feelings
- Avoid external reminders of event (e.g. people, places, situations or activities)
- NEGATIVE MOOD or Thought Process since the event (2 or more of the following)
- Key details of the event are not remembered
- Persistent negativity about self and others since the event
- Distorted thoughts about causes and consequences of the Traumatic event
- Persistent negative emotions (e.g. fear, guilt or anger)
- Avoidance of previously pleasurable activities
- Detachment from others (family, friends)
- Inability to experience happiness, satisfaction or other positive emotions
- Increased AROUSAL or reactivity since event (2 or more)?
- Outbursts of anger or irritability with minimal provocation
- Reckless behavior
- Hypervigilance
- Increased startle reaction
- Difficult concentration
- Insomnia
- Modifiers
- Delayed expression (manifests >6 months after event)
- Dissociation
- Depersonalization
- Sense of detachment from self (feelings, body)
- As if observing self from another person's perspective
- Derealization
- Sense that surrounding world is unreal
- Depersonalization
- References
- (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, APA, Washington, DC, p. 271-2
XI. Management: General Approach
- Evaluate for Suicidality
- Requires immediate management
- Assess for associated conditions
- Traumatic Brain Injury
- Chemical Dependency
- Up to 40% of PTSD patients meet criteria for Alcohol Use Disorder
- Chemical use significantly increases Suicide Risk
- Mood Disorder
- Major Depression is comorbid in up to 50% of PTSD patients
- Reassurance
- PTSD is a reaction to the stress of Trauma
- Predictable course and often resolves with treatment
- Anticipatory guidance
- Prepare patient for possible symptoms in future
- Be careful in somatizing or suggestible patients
- Cognitive behavioral approaches (individual or group therapy)
- Psychotherapy is a preferred first-line therapy with long lasting effects
- Medications, if needed, should only be adjunctive
- Typically consists of weekly or twice weekly sessions, 60 to 90 minutes each, for 6 to 12 weeks
- Cognitive processing therapy
- Challenge maladaptive beliefs about safety, trust, esteem
- Prolonged exposure therapy
- Breathing retraining to decrease arousal
- Repeated remembering of Trauma to teach memories are not dangerous
- Re-exposure to real world, feared situations
- References
- Psychotherapy is a preferred first-line therapy with long lasting effects
XII. Management: Medications - General Approach
- Efficacy
- Precautions
-
Selective Serotonin Reuptake Inhibitor (SSRI)
- Sertraline (Zoloft) - FDA approved for PTSD
- Paroxetine (Paxil) - FDA approved for PTSD
- Citalopram (Celexa)
- Escitalopram (Lexapro)
- Fluoxetine (Prozac)
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
- Other agents that may improve symptoms
XIII. Management: Medications - Specific Indications
- Dissociative flashbacks or intrusive memories
- Propranolol (Inderal) 10-20 mg PO qid prn
-
Nightmares of Trauma
- Prazosin (Minipress)
- May decrease sympathetic tone during sleep (mixed efficacy)
- Raskind (2018) N Engl J Med 378(6): 507-17 [PubMed]
- Zhang (2020) Sleep Med 67:225-31 [PubMed]
- Prazosin (Minipress)
-
Sleep Disturbance or Insomnia
- Screen for Obstructive Sleep Apnea
- Obstructive Sleep Apnea is found in up to 75% of patients with PTSD (at least moderate in 50%)
- Zhang (2017) Sleep Med 36:125-32 [PubMed]
- Cognitive Behavioral Therapy for Insomnia (preferred longterm)
- Sedative-Hypnotics (short-term)
- Other medications that have been used
- Cyproheptadine (Periactin) 4 mg PO qhs
- Trazodone
- Screen for Obstructive Sleep Apnea
- Hallucinations of the Trauma (or PTSD refractory to SSRI/SNRI therapy)
- Avoidance, numbing Sensation or diminished interests
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
- Hyperarousal or Irritability
- Propranolol (Inderal) 10-20 mg PO qid prn
- Buspirone (Buspar)
- Benzodiazepines are not recommended
- Risk of paraxodical worsening of PTSD symptoms
- No evidence of benefit and risk of dependence
- Marijuana is not recommended
- No evidence of benefit and may worsen symptoms
- Mixed PTSD Symptoms - Mood stabilizers (based on weak evidence)
- Divalproex (Depakote) 250-500 mg tid (or 750 mg qhs)
- Carbamazepine (Tegretol) 400-800 mg PO qd
- Lamotrigine (Lamictal)
- Topiramate (Topamax)
- Gabapentin (Neurontin)
- Lithium
XIV. Prevention
XV. Resources
- National Center for PTSD
- Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury
- National Child Traumatic Stress Network
- SAMHSA National Help Line (for patients, staffed 24/7)
- PTSD Treatments (AHRQ)
XVI. References
- (2017) Presc Lett 24(10): 58
- Butler (1999) Am Fam Physician 60(2):524-30 [PubMed]
- Bowles (2000) Am Fam Physician 61(6):1689-96 [PubMed]
- Sartor (2023) Am Fam Physician 107(3): 273-81 [PubMed]
- Ursano (2004) Am J Psychiatry 161(11 suppl): 3-31 [PubMed]
- Warner (2013) Am Fam Physician 88(12): 827-34 [PubMed]
- Williams (2022) Cochrane Database Syst Rev (3): CD002795 [PubMed]